Role of Merlin/NF2 Inactivation in Tumor Biology

por Petrilli, Alejandra M., Fernández-Valle, Cristina
Publicado 2015

Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis

por Petrilli, Alejandra M., Bott, Marga, Fernández-Valle, Cristina
Publicado 2013

Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology

por Nunez Lopez, Yury O., Iliuk, Anton, Petrilli, Alejandra M., Glass, Carley, Casu, Anna, Pratley, Richard E.
Publicado 2022

Coordinated regulation of gene expression and microRNA changes in adipose tissue and circulating extracellular vesicles in response to pioglitazone treatment in humans with type 2...

por Nunez Lopez, Yury O., Casu, Anna, Kovacova, Zuzana, Petrilli, Alejandra M., Sideleva, Olga, Tharp, William G., Pratley, Richard E.
Publicado 2022

The proteome and phosphoproteome of circulating extracellular vesicle-enriched preparations are associated with characteristic clinical features in type 1 diabetes

por Casu, Anna, Nunez Lopez, Yury O., Yu, Gongxin, Clifford, Christopher, Bilal, Anika, Petrilli, Alejandra M., Cornnell, Heather, Carnero, Elvis Alvarez, Bhatheja, Ananya, Corbin, Karen D., Iliuk, Anton, Maahs, David M., Pratley, Richard E.
Publicado 2023

Ponatinib promotes a G(1) cell-cycle arrest of merlin/NF2-deficient human schwann cells

por Petrilli, Alejandra M, Garcia, Jeanine, Bott, Marga, Plati, Stephani Klingeman, Dinh, Christine T, Bracho, Olena R, Yan, Denise, Zou, Bing, Mittal, Rahul, Telischi, Fred F, Liu, Xue-Zhong, Chang, Long-Sheng, Bradley, D Welling, Copik, Alicja J, Fernández-Valle, Cristina
Publicado 2017

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2

por Allaway, Robert, Angus, Steve P., Beauchamp, Roberta L., Blakeley, Jaishri O., Bott, Marga, Burns, Sarah S., Carlstedt, Annemarie, Chang, Long-Sheng, Chen, Xin, Clapp, D. Wade, Desouza, Patrick A., Erdin, Serkan, Fernandez-Valle, Cristina, Guinney, Justin, Gusella, James F., Haggarty, Stephen J., Johnson, Gary L., La Rosa, Salvatore, Morrison, Helen, Petrilli, Alejandra M., Plotkin, Scott R., Pratap, Abhishek, Ramesh, Vijaya, Sciaky, Noah, Stemmer-Rachamimov, Anat, Stuhlmiller, Tim J., Talkowski, Michael E., Welling, D. Bradley, Yates, Charles W., Zawistowski, Jon S., Zhao, Wen-Ning
Publicado 2018

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

por Chang, Long-Sheng, Oblinger, Janet L., Smith, Abbi E., Ferrer, Marc, Angus, Steven P., Hawley, Eric, Petrilli, Alejandra M., Beauchamp, Roberta L., Riecken, Lars Björn, Erdin, Serkan, Poi, Ming, Huang, Jie, Bessler, Waylan K., Zhang, Xiaohu, Guha, Rajarshi, Thomas, Craig, Burns, Sarah S., Gilbert, Thomas S. K., Jiang, Li, Li, Xiaohong, Lu, Qingbo, Yuan, Jin, He, Yongzheng, Dixon, Shelley A. H., Masters, Andrea, Jones, David R., Yates, Charles W., Haggarty, Stephen J., La Rosa, Salvatore, Welling, D. Bradley, Stemmer-Rachamimov, Anat O., Plotkin, Scott R., Gusella, James F., Guinney, Justin, Morrison, Helen, Ramesh, Vijaya, Fernandez-Valle, Cristina, Johnson, Gary L., Blakeley, Jaishri O., Clapp, D. Wade
Publicado 2021